Wells Fargo & Company Altamira Therapeutics Ltd. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
N/A
-8,435 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
N/A
4,100 Added 94.58%
8,435 $30,000
Q1 2021

May 13, 2021
BUY
N/A
500 Added 13.04%
4,335 $15,000
Q4 2020

Feb 09, 2021
BUY
N/A
3,835 New
3,835 $10,000

About Altamira Therapeutics Ltd.

EARS Quotes by TradingView
  • Ticker EARS
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,869,600
  • Market Cap $39.2M
More about EARS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email